Notably, aberrations in the PI3K/AKT pathway can initiate numerous downstream pathways that contribute to tumorigenesis [38, 39], and the pathway’s deregulation is known to enhance glioblastoma invasion by increasing tumor cell mobility and stress resistance, thus presenting a viable target for glioblastoma treatment [40, 41]. The gene discussed is AKT1; the disease is neoplasm.